Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 134

Instacart aims for IPO at $30bn valuation

The Amazon, Comcast and American Express-backed grocery delivery service is reportedly looking at early next year for an offering that would hike its valuation 70%.

Nov 13, 2020

Pkware picks up Dataguise

Samsung Next's data security portfolio company Dataguise has been acquired after raising moe than $20m in funding since 2007.

Nov 13, 2020

Snap grabs Voca.ai in $70m acquisition

The voice analytics software provider has reportedly been bought by Snap after raising about $6m from investors including American Express Ventures.

Nov 13, 2020

Silverback goes for IPO gold

The cancer immunothrapy developer has filed to raise up to $100m in an offering that will follow $211m from backers including Celgene and Bristol-Myers Squibb.

Nov 12, 2020

Brown & Brown gives CoverHound a home

The acquisition of insurance marketplace CoverHound comes after $112m in funding from investors including Hiscox, Chubb, MS&AD, Aflac Ventures, Ace Group and American Family Ventures.

Nov 11, 2020

Adobe to administer $1.5bn Workfront acquisition

Susquehanna International Group is set to exit the marketing collaboration software developer having invested just over a year ago.

Nov 10, 2020

ShopKeep reaches Lightspeed in $440m deal

First Data and Salesforce Ventures are set to exit the digital commerce technology provider after it agreed to be purchased for $440m in cash and stock.

Nov 9, 2020

Analysis: Ant in the balance

China-based financial services provider Ant Group, spun off by e-commerce group Alibaba, intended to float on the Shanghai and Hong Kong stock markets.

Nov 9, 2020

Kuaishou broadcasts IPO filing

The Baidu and Tencent-backed video streaming platform developer has filed for a Hong Kong offering that could potentially value it at $50bn.

Nov 6, 2020

Merck & Co marks $2.75bn VelosBio purchase

Takeda Ventures and Chiesi Ventures are set to exit the cancer drug developer through the deal, which came after just over $200m in funding.

Nov 6, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here